ArticleThe Lancet. Infectious diseases2022

Real-world effectiveness of early molnupiravir or nirmatrelvir-ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study.

Carlos K H Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.